Impact of reimbursement program "Аffordable Medicines" on consumptiom of betablockers in Ukraine in 2017-2020
the article presents the results of the study of impact of the reimbursement program "Affordable medicines" on consumption of beta-blockers in Ukraine, used for treatment of cardiovascular diseases. Analysis was conducted based on analytical data of Ukrainian pharmaceutical market research...
Saved in:
Main Authors: | Anton Gonchar (Author), Natalia Sholoiko (Author) |
---|---|
Format: | Book |
Published: |
Bogomolets National Medical University,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of dynamics of the drug list in the аffordable medicines program for treatment of cardiovascular diseases
by: V. S. Huz, et al.
Published: (2019) -
Reimbursement of combined antihypertensive medicenes in Ukraine: aspects of inclusion and external reference pricing
by: A. O. Gonchar, et al.
Published: (2022) -
Effect of betablockers on the course of Martorell hypertensive ulcers: a retrospective study
by: Lucy Cleusix, et al.
Published: (2024) -
Content analysis of the official documents on the turnover of counterfeit medicines in Ukraine in 2017-2020
by: S. О. Lebed, et al.
Published: (2021) -
Analysis of oral hypoglycemic drugs that are subject to reimbursement in Ukraine
by: I. O. Vlasenko
Published: (2022)